
wojciech_piotr_krajewski
@wojciechpiotrk1
MD, PhD
Department of Minimally Invasive and Robotic Urology
University Center of Excellence in Urology
Wrocław Medical University
ID: 1091032841272651781
31-01-2019 17:57:54
316 Tweet
407 Followers
342 Following

📊👨⚕️ Explore the most-viewed content of November 2023 on #SIUAcademy! See which Top 10 picks are shaping discussions in the field of #Urology. #WeBringUrologistsTogether #SIUWorld Discover the Top 10 List bit.ly/3tdytmm wojciech_piotr_krajewski Nadia Abid


Retrograde intrarenal surgery using the ILY robotic flexible ureteroscope: a single centre experience ceju.online/journal/2023/u… - via Central European Journal of Urology

Patients with very high-risk non muscle invasive #bladdercancer who receive adequate BCG therapy: ✅ Have a more favorable prognosis than predicted by EAU risk groups, especially among those with a sustained response sciencedirect.com/science/articl… EAU Young Urologists EAU Young Academics


Our latest SR and MA "Clinical and Oncological Outcomes Following Percutaneous Cryoablation vs. Partial Nephrectomy for Clinical T1 Renal Tumours: Systematic Review and Meta-Analysis" is now available. wojciech_piotr_krajewski Bartosz Malkiewicz Joanna Chorbińska Francesco, Del Giudice


#HoLEP at #BPO Update SIU-Urology by Wojciech Krajewski Mauro GACCI StavrosGravas scoffone cesare SIU-Urology Nice


Nice depicting of apical urethra rather than apical mucosa sparing. by cutting the mucosa we also preserve the underlying structures such as #lisso #sphincter. #Urethrasparing SIU-Urology #BPO update Wojciech Krajewski


FANS are becoming a standard! Another step forward in providing top-notch care for our patients with urolithiasis! 1550 HU 20 x 17 mm stone removed in 42 min. 11/13 ClearPetra UAS 8.5 Fr Hawk ureteroscope wojciech_piotr_krajewski Bartosz Malkiewicz Joanna Chorbińska

Great experience to present about bladder sparing strategies in MIBC patients at the national Polish association meeting. Congrats Pawel Rajwa and wojciech_piotr_krajewski for the great work !


🤩 Wonderful days in 🇵🇱 with new & old friends at PTU national congress! 🙏 for the great hospitality & see you soon Pawel Rajwa Bartosz Malkiewicz wojciech_piotr_krajewski European Association of Urology (EAU) EAU Edu Platform UROONCO EAU Young Academics EAU YAU Prostate Cancer Working Group


Endourology Academy Upcoming Webinar! Join us on Oct 4, 2024 at 2 PM CET for "New Game Changers in RIRS: How to Choose the Correct Technology" supported by ClearPetra-Well Lead Registration: endourologyacademy.com/webinar/23


Dr wojciech_piotr_krajewski will discuss about "Suction during ECIRS : Does it really help?" during Endourology Academy webinar "New game changers in RIRS: How to choose the correct technology." Webinar registration: endourologyacademy.com/webinar/23 supported by ClearPetra-Well Lead


20th HoLEP procedure 90 ml Enucleaction + morcellation = 60 min Early apical release Catheter removed 24h after procedure Full continence Full of gratitude to wojciech_piotr_krajewski for constant tutoring


Gratulacje dla organizatorów 11 Sympozjum Sekcji Urologii Onkologicznej PTU Prof.Roman Sosnowski Pawel Rajwa wojciech_piotr_krajewski . Świetne spotkanie merytoryczne oraz świetni wykładowcy !! Artur Leminski Bartosz Malkiewicz Marcin Słojewski Artur A. Antoniewicz



Olivier Traxer Preparations on the way from the EAU Endourology Stone Surgical Team for the best congress of all times #ICE25 😉💪🏻🔥




Honored to become an Associate Member of the YAU Endourology & Urolithiasis Group! Looking forward to exciting new scientific collaborations and advancing research in the field. I am deeply grateful for the invaluable scientific mentorship of wojciech_piotr_krajewski


Histological subtypes/divergent differentiation (HS/DD) in UTUC = worse outcomes. In a review of 14,407 patients, HS/DD linked to higher stage/grade, more LNI/LVI, and worse CSS, OS, RFS. Detection should prompt aggressive tx + close follow-up. kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

Our new SR and MA published in European Urology Oncology evaluates focal therapy for localized PCa using prospective data only. Important for patient counselling. 📊 50 studies, 4,615 patients 📊 12-mo csPCa RFS in intermediate-risk: 79% (95% CI 74–83%) 🔗 doi.org/10.1016/j.euo.…
